Last reviewed · How we verify
Extubation T
At a glance
| Generic name | Extubation T |
|---|---|
| Also known as | Ultiva |
| Sponsor | Seganest |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Prophylactic Use of APRV Before Extubation in Morbidly Obese Patients After Cardiac Surgery. (NA)
- One-Hour Positive Pressure Ventilation After a T-Piece Spontaneous Breathing Trial (NA)
- Extubation Safety Via Microstream EtCO₂ (IPI) Monitoring (NA)
- Pressure Support and Positive End Expiratory Pressure During Spontaneous Breathing Trial (NA)
- Eyecontrol coMmunication Platform for dEliRium manaGemEnt in Intensive Care Units (EMERGE) (NA)
- Continuous Positive Airway Pressure (CPAP) Pediatric Patients With Subglottic Stenosis Who Undergo Balloon Dilatation (NA)
- Spontaneous Breathing Trials Using Pressure Support or T-Piece in Overweight and Obese Patients (NA)
- The Use of ExPreS in the Weaning of Patients in Invasive Mechanical Ventilation (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Extubation T CI brief — competitive landscape report
- Extubation T updates RSS · CI watch RSS
- Seganest portfolio CI